Latest News in the pharma Industry

All

Positive results for Lilly's three Phase III studies of galcanezumab for the prevention of migraine

Positive results for Lilly's three Phase III studies of galcanezumab for the prevention of migraine

14 May 2017

Read more 
Genentech to present new data on personalized medicines and cancer immunotherapies

Genentech to present new data on personalized medicines and cancer immunotherapies

12 May 2017

New pivotal results for Perjeta and Alecensa demonstrating improvement over standards of care.

Read more 
Avastin as effective as Eylea for treating central retinal vein occlusion

Avastin as effective as Eylea for treating central retinal vein occlusion

12 May 2017

NIH-funded clinical trial shows use of either drug improved vision and had few side effects.

Read more 
Hikma receives CRL regarding its ANDA for generic Advair Diskus

Hikma receives CRL regarding its ANDA for generic Advair Diskus

11 May 2017

Company believes low likelihood of approval this year.

Read more 
Merck's Keytruda scores another FDA approval

Merck's Keytruda scores another FDA approval

11 May 2017

FDA approves Keytruda as first-line combination therapy with pemetrexed and carboplatin for patients with metastatic nonsquamous non-small cell lung cancer (NSCLC) irrespective of PD-L1 expression.

Read more 
Takeda terminates plans for Vaxem Hib launch in Japan

Takeda terminates plans for Vaxem Hib launch in Japan

11 May 2017

Discontinuation due to the vaccine supplier’s (GSK) decision to discontinue global production.

Read more 
New licensing program facilitates adoption of Tandem Mass Tag technology

New licensing program facilitates adoption of Tandem Mass Tag technology

10 May 2017

Thermo Fisher Scientific helps research service providers and their customers optimize protein identification and quantitation.

Read more 
Croda celebrates EXCiPACT Certification across all leading excipient sites

Croda celebrates EXCiPACT Certification across all leading excipient sites

10 May 2017

Status marks the company as the first multi-site excipient supplier to achieve global EXCiPACT accreditation across its production facilities.

Read more 
Gyros Protein Technologies introduces next generation Gyrolab Protein A Kit for biotherapeutics

Gyros Protein Technologies introduces next generation Gyrolab Protein A Kit for biotherapeutics

10 May 2017

Kit increases efficiency of residual protein A ligand detection.

Read more 
Roche's Tecentriq flops during Phase III trial

Roche's Tecentriq flops during Phase III trial

10 May 2017

IMvigor211 failed to meet its primary endpoint of overall survival (OS) compared with chemotherapy.

Read more 
CPhI Worldwide Advisory Board returns with five new global experts

CPhI Worldwide Advisory Board returns with five new global experts

9 May 2017

Board helps to steer the overall development of CPhI events and content.

Read more 
Optibrium and Goldfinch Bio sign agreement for StarDrop license

Optibrium and Goldfinch Bio sign agreement for StarDrop license

9 May 2017

Goldfinch Bio’s researchers select StarDrop to guide successful drug discovery.

Read more